Seasonal malaria chemoprevention (SMC) is an intervention that has been recommended by WHO since 2012 to prevent malaria cases in children under five in areas where malaria transmission is highly seasonal. Successful SMC delivery entails high coverage in terms of children receiving complete treatment courses using two antimalarial medicines: sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ), or ‘SPAQ’. A key challenge of implementation is ensuring the successful administration of each monthly course by caregivers: some may skip doses, while some children might refuse to take the medicines. This study looked at using an innovative social and behaviour change approach, the role model approach, to address community challenges in implementing SMC.
This poster was presented at the 71st annual meeting of the American Society of Tropical Medicine and Hygiene.
Country: ChadKeywords: Community delivery | Malaria | Seasonal malaria chemoprevention | SDG3
« Back to Publications